Search

Your search keyword '"Kinoshita, Ikuharu"' showing total 6 results
Start Over Author "Kinoshita, Ikuharu"
6 results on '"Kinoshita, Ikuharu"'

2. Multicenter randomized control study of the efficacy of SO clip in colorectal endoscopic submucosal dissection (ESD). (SO clip study in colorectal ESD): Randomized controlled trial

Author

Taki, Shinya, primary, Iguchi, Mikitaka, additional, Fukatsu, Kazuhiro, additional, Shimokawa, Toshio, additional, Kinoshita, Ikuharu, additional, Syunsuke, Ogata, additional, Maekita, Takao, additional, Kinoshita, Jun, additional, Takao, Masaki, additional, and Kitano, Masayuki, additional

Published
2023
Full Text
View/download PDF

3. Histology of metastatic colorectal cancer in a lymph node

Author

Yokoyama, Shozo, primary, Watanabe, Takashi, additional, Fujita, Yoichi, additional, Matsumura, Shuichi, additional, Ueda, Katsuya, additional, Nagano, Shotaro, additional, Kinoshita, Ikuharu, additional, Murakami, Daisuke, additional, Tabata, Hirotaka, additional, Tsuji, Toshiaki, additional, Ozawa, Satoru, additional, Tamaki, Takuya, additional, Nakatani, Yoshihiro, additional, and Oka, Masami, additional

Published
2023
Full Text
View/download PDF

4. The Lymph Node Metastasis Histology in Colorectal Cancer -The Clinical Implication of Tubular-Type Carcinoma in Lymph Nodes -

Author

Yokoyama, Shozo, primary, Watanabe, Takashi, additional, Fujita, Yoichi, additional, Matsumura, Shuichi, additional, Ueda, Katsuya, additional, Kinoshita, Ikuharu, additional, Murakami, Daisuke, additional, Tabata, Hirotaka, additional, Tsuji, Toshiaki, additional, Ozawa, Satoru, additional, Tamaki, Takuya, additional, Nakatani, Yoshihiro, additional, and Oka, Masami, additional

Published
2021
Full Text
View/download PDF

6. [A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene].

Author

Matsumura M, Tashiro K, Miura A, Tajima T, Kinoshita I, Kojima E, and Yoshizawa A

Subjects
Aged, Female, Humans, Non-alcoholic Fatty Liver Disease, Osteoporosis drug therapy, Fatty Liver physiopathology, Raloxifene Hydrochloride adverse effects, Selective Estrogen Receptor Modulators adverse effects
Abstract

A 70-year-old woman presented with abnormal liver function test 3 months after the introduction of daily intake of raloxifene, a selective estrogen receptor modulator, for osteoporosis. She had a history of NAFLD, diabetes mellitus and depression. The ratio of the computed-tomographic value of the liver against that of the spleen decreased remarkably. Pathological examination of the liver biopsy revealed severe steatosis. We thought her NAFLD was aggravated by raloxifene and discontinued the drug. The liver function test results improved and the computed tomographic liver-spleen ratio rose. This is the second case report of NAFLD becoming aggravated after treatment with raloxifene. It still remains unclear how raloxifene affects liver. Monitoring liver function is recommended when treating with raloxifene.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results